Ryvu Therapeutics Investor Relations Material
Latest events
Study Update
Ryvu Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Ryvu Therapeutics S A
Access all reports
Ryvu Therapeutics S.A. is a Poland-based biotechnology company focused on the research and development of novel small molecule therapies. The company specializes in discovering and developing treatments for cancer, particularly in the areas of targeted therapies and immuno-oncology. Ryvu conducts both early-stage discovery and clinical development activities, with a pipeline supported by internal research capabilities and collaborative partnerships. The company is headquartered in Kraków, Poland, and its shares are listed on the WSE.
Key slides for Ryvu Therapeutics S A
Corporate Presentation
Ryvu Therapeutics S A
Study Update
Ryvu Therapeutics S A
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
RVU
Country
🇵🇱 Poland